Status:
UNKNOWN
Platelet Gel in Systemic Sclerosis
Lead Sponsor:
Università Politecnica delle Marche
Conditions:
Scleroderma, Systemic
Eligibility:
All Genders
18-80 years
Phase:
PHASE2
PHASE3
Brief Summary
* Systemic sclerosis (scleroderma; SSc) is a connective tissue disease characterized by a progressive fibrosis of the skin and visceral organs. * A diffuse cutaneous microvascular damage occurs in 30-...
Eligibility Criteria
Inclusion
- Digital ulcers (NPUAP stage≥2) in patients with SSc (ACR criteria)
- Current medical treatment with intravenous prostanoids
- Availability to come to our centre for weekly ulcer assessment and medication
- Capacity to give informed consent
Exclusion
- Clinical evidence of skin infection
- Current treatment with Bosentan or Sildenafil
- Presence of necrotic material occluding the wound bed.
Key Trial Info
Start Date :
March 1 2007
Trial Type :
INTERVENTIONAL
End Date :
March 1 2008
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT00463125
Start Date
March 1 2007
End Date
March 1 2008
Last Update
April 20 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Università politecnica delle marche
Ancona, Italy, 60020